Health
Messenger RNA vaccines lower risk for asymptomatic infection, study finds – Healio
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world…
Participants who received two doses of a messenger RNA COVID-19 vaccine were 80% less likely to test positive for asymptomatic SARS-CoV-2, according to real-world study results published in Clinical Infectious Diseases.
Even after one dose, the risk for asymptomatic infection was reduced by 79%, researchers reported. The two messenger RNA vaccines authorized for use in the United States are made by Pfizer-BioNTech and Moderna.
“As people are undergoing their routine care and they’re caring for…
-
Noosa News13 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News18 hours agoBrisbane news live: Federal fund for council’s cyclone clean-up dries up
-
Noosa News20 hours agoDifficult to diagnose and potentially deadly — this lesser-known disease is becoming more common
-
Noosa News21 hours agoCountdown on for Noosa Eat & Drink Festival 2025